EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effect of first-line poly(ADP-ribose) polymerase inhibitor on second-line platinum-based chemotherapy in epithelial ovarian cancer

Yusuke Toyohara iD, Mayu Yunokawa iD, Ryo Nimura iD, Eitaro Funada iD, Risako Ozawa iD, Kei Kato iD, Shogo Nishino iD, Mayumi Kamata iD, Motoko Kanno iD, Atsushi Fusegi iD, Akiko Abe iD, Sachiho Netsu iD und 6 weitere

Journal of Gynecologic Oncology · 2026 · 37 (4)

DOI: 10.3802/jgo.2026.37.e82 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Yusuke Toyohara und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) Polymerase InhibitorsCarcinoma, Ovarian EpithelialOvarian NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleRetrospective StudiesMiddle AgedNeoplasm Recurrence, LocalAgedProgression-Free SurvivalAdultMaintenance Chemotherapy

Stichwörter der Autor:innen

Drug Resistance, NeoplasmOvarian NeoplasmsPlatinum CompoundsPoly(ADP-ribose) Polymerase InhibitorsRecurrence

Substanzen

Poly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Department of Gynecology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Department of Gynecology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. mayu.yunokawa@jfcr.or.jp.

ORCID-Profile: Yusuke Toyohara, Mayu Yunokawa, Ryo Nimura, Eitaro Funada, Risako Ozawa, Kei Kato, Shogo Nishino, Mayumi Kamata, Motoko Kanno, Atsushi Fusegi, Akiko Abe, Sachiho Netsu, Makiko Omi, Yoichi Aoki, Terumi Tanigawa, Sanshiro Okamoto, Hidetaka Nomura, Hiroyuki Kanao

Zitieren

APA

Toyohara, Y., Yunokawa, M., Nimura, R., Funada, E., Ozawa, R., Kato, K., Nishino, S., Kamata, M., Kanno, M., Fusegi, A., Abe, A., Netsu, S., Omi, M., Aoki, Y., Tanigawa, T., Okamoto, S., Nomura, H., & Kanao, H. (2026). Effect of first-line poly(ADP-ribose) polymerase inhibitor on second-line platinum-based chemotherapy in epithelial ovarian cancer. Journal of Gynecologic Oncology, 37(4). https://doi.org/10.3802/jgo.2026.37.e82

Vancouver

Toyohara Y, Yunokawa M, Nimura R, Funada E, Ozawa R, Kato K, et al. Effect of first-line poly(ADP-ribose) polymerase inhibitor on second-line platinum-based chemotherapy in epithelial ovarian cancer. Journal of Gynecologic Oncology. 2026;37(4). doi:10.3802/jgo.2026.37.e82

BibTeX
@article{Toyohara2026,
  author = {Toyohara, Yusuke and Yunokawa, Mayu and Nimura, Ryo and Funada, Eitaro and Ozawa, Risako and Kato, Kei and Nishino, Shogo and Kamata, Mayumi and Kanno, Motoko and Fusegi, Atsushi and Abe, Akiko and Netsu, Sachiho and Omi, Makiko and Aoki, Yoichi and Tanigawa, Terumi and Okamoto, Sanshiro and Nomura, Hidetaka and Kanao, Hiroyuki},
  title = {Effect of first-line poly(ADP-ribose) polymerase inhibitor on second-line platinum-based chemotherapy in epithelial ovarian cancer},
  journal = {Journal of Gynecologic Oncology},
  year = {2026},
  volume = {37},
  number = {4},
  doi = {10.3802/jgo.2026.37.e82}
}
Kostenlos starten →